![](https://soar-rd.shinshu-u.ac.jp/search/content/images/noimage.png)
NISHIZAWA OSAMU
Shinshu University Hospital Clinical Division of Urology
Professors
Researcher Information
Research activity information
Paper
- Comparison of efficacy and safety of 1- and 3-month luteinizing hormone-releasing hormone agonist depots as initial therapiesfor prostate cancer.
Ishizuka, O; Nishizawa, O; Nishizawa, S; Satoh, T; Wajiki, M; Kiyokawa, H; Inoue, Y; Kobayashi, S; Mizusawa, H; Nakagawa, T
Int J Clin Oncol, 18(3), 524-530, 2013 - Randomized Controlled Trial to Treat Benign Prostatic Hyperplasia with Overactive Bladder Using an Alpha-blocker Combined with Anticholinergics.
Nishizawa O, Yamaguchi O, Takeda M, Yokoyama O, for the TAABO Study Group
LUTS, 3(1), 29-35, 2011 - Implantation of autologous bone-marrow-derived cellsreconstructs functional urethral sphincters in rabbits.
Imamura T, Ishizuka O, Kinebuchi Y, Kurizaki Y, Nakayama T, Ishikawa M, Nishizawa O
Tissue Eng Part A, 17(7-8), 1069-1081, 2011 - Early efficacy of an alpha 1 adrenoceptor antagonist, naftopidil, againt lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Ishizuka O, Nishizawa O, Takeda M, Nomura T, Kagawa S
LUTS, 3, 79-85, 2011 - Relation between expression of α1-adrenoceptor mRNAs in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms.
Kurizaki Y, Ishizuka O, Imamura T, Ichino M, Ogawa T, Igawa Y, Nishizawa O, Andersson KE
Scand J Urol Nephrol, 45(1), 15-19, 2011 - Analysis of the pressure-flow study in weak detrusor patients with benign prostatic hypertrophy.
Tanabe T, Ishizuka O, Ichino M, Ogawa T, Imamura T, Kurizaki Y, Iijima K,Nishizawa O
LUTS, 3, 109-112, 2011 - Randomized Controlled Trial to Treat Benign Prostatic Hyperplasia with Overactive Bladder Using an Alpha-blocker Combined with Anticholinergics.
Nishizawa O, Yamaguchi O, Takeda M, Yokoyama O, for the TAABO Study Group
LUTS, 3(1), 29-35, 2011 - Predictive factors for the effect of the ホア1-D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogenic lower urinary tract dysfunction.
Takeda M, Homma Y, Araki I, Kakizaki H, Yamanishi T, Yokota T, Gotoh M, Igawa Y, Seki N, Takei M, Yoshida M, Sugaya K, Nishizawa O; Japanese Naftopidil Neurogenic Lower Urinary Tract DysfunctionStudy Group
BJU Int, 108(1), 100-107, 2011 - Analysis of the pressure-flow study in weak detrusor patients with benign prostatic hypertrophy
Tanabe, T., Ishizuka, O., Ichino, M., Ogawa, T., Imamura, T., Kurizaki, Y., Iijima, K, Nishizawa, O
LUTS, 3, 109-112, 2011 - Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms--ASSIST, randomized controlled study
Yamaguchi O, Kakizaki H, Homma Y, Takeda M, Nishizawa O, Gotoh M, Yokoyama O, Seki N, Yoshida M; ASSIST Study Group
Urology, 78(1), 126-133, 2011 - IJU this issue
Nishizawa O
Int J Urol, 18(10), 683, 2011